This is a preview of subscription content, log in via an institution to check access.
Reference
Kuang RZ, et al. Effects of Apatinib combined with Temozolomide on levels of sPD-1 and sPD-L1 in patients with drug-resistant recurrent glioblastoma. Clinics (Sao Paulo, Brazil) 79: Dec 2024. Available from: URL: https://dx.doi.org/10.1016/j.clinsp.2024.100376
Rights and permissions
About this article
Cite this article
Rivoceranib/temozolomide. Reactions Weekly 2011, 382 (2024). https://doi.org/10.1007/s40278-024-60617-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-60617-9